|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.79 HKD | +1.70% |
|
-2.04% | -30.56% |
| 06-25 | 3Sbio Inc. Declares a Final Dividend for the Year Ended 31 December 2025 | CI |
| 05-29 | Innovent Biologics, Pfizer strike $10.5 bln cancer drug deal amid China biotech boom | RE |
| Market Cap | 35.45B 41.15B 5.25B 4.56B 4.26B 3.91B 7.37B 500B 7.5B 50.2B 19.66B 249B 19.71B 19.27B 823B | P/E 2026 * |
13.5x | P/E 2027 * | 13.5x |
|---|---|---|---|---|---|
| Enterprise Value | 22.82B 26.49B 3.38B 2.94B 2.74B 2.52B 4.74B 322B 4.83B 32.31B 12.66B 161B 12.69B 12.4B 529B | EV / Sales 2026 * |
2.26x | EV / Sales 2027 * | 2.03x |
| Free-Float |
74.93% | Yield 2026 * |
1.68% | Yield 2027 * | 1.82% |
| 1 day | +1.70% | ||
| 1 week | -2.04% | ||
| Current month | +0.42% | ||
| 1 month | -13.68% | ||
| 3 months | -25.97% | ||
| 6 months | -28.49% | ||
| Current year | -30.56% |
| 1 week | 16.16 |  | 17.73 |
| 1 month | 15.61 | | 20.9 |
| Current year | 14.81 | | 29.3 |
| 1 year | 14.81 | | 36.8 |
| 3 years | 4.91 | | 36.8 |
| 5 years | 4.72 | | 36.8 |
| 10 years | 4.72 | | 36.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jing Lou
CEO | Chief Executive Officer | 63 | 01/01/2006 |
Xiang He
DFI | Director of Finance/CFO | 43 | 03/07/2023 |
Dong Mei Su
PRN | Corporate Officer/Principal | 56 | 27/11/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Jing Lou
CHM | Chairman | 63 | 03/04/2012 |
Dong Mei Su
BRD | Director/Board Member | 56 | 11/06/2012 |
Tian Ruo Pu
BRD | Director/Board Member | 57 | 01/06/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 29/07/25 | Other | Chief Executive Officer | 440,000 | 0.0184% | ||
| 15/04/25 | Other | Director | 26,000 | 0.0011% | ||
| 11/04/25 | Other | Director | 460,000 | 0.0192% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.70% | -2.04% | -44.91% | +130.95% | 5.25B | |
| -0.44% | +13.80% | +35.85% | -1.58% | 75.81B | |
| +1.63% | -10.07% | +21.85% | +182.81% | 48.57B | |
| -4.18% | +42.30% | +42.30% | +42.30% | 46.01B | |
| +3.64% | +7.79% | -51.37% | -51.41% | 41.66B | |
| -0.56% | +0.84% | +52.95% | -24.62% | 29.82B | |
| -0.91% | -0.37% | +56.67% | +82.26% | 24.01B | |
| +0.58% | -0.88% | +99.75% | -49.85% | 22.01B | |
| +0.93% | -3.45% | -6.57% | +164.63% | 19.09B | |
| -0.05% | -6.51% | +61.75% | +115.83% | 15.83B | |
| Average | +0.23% | -1.13% | +26.83% | +59.13% | 32.81B | |
| Weighted average by Cap. | +0.02% | +0.87% | +28.46% | +43.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.11B 11.73B 1.5B 1.3B 1.21B 1.11B 2.1B 143B 2.14B 14.31B 5.61B 71.11B 5.62B 5.49B 235B | 10.43B 12.11B 1.54B 1.34B 1.25B 1.15B 2.17B 147B 2.21B 14.77B 5.79B 73.4B 5.8B 5.67B 242B |
| Net income | 2.73B 3.17B 404M 351M 328M 301M 568M 38.54B 578M 3.87B 1.52B 19.22B 1.52B 1.49B 63.39B | 2.69B 3.13B 399M 347M 324M 297M 560M 38.01B 570M 3.82B 1.49B 18.95B 1.5B 1.46B 62.52B |
| Net Debt | -12.63B -14.66B -1.87B -1.62B -1.52B -1.39B -2.63B -178B -2.67B -17.89B -7.01B -88.86B -7.02B -6.87B -293B | -14.26B -16.56B -2.11B -1.83B -1.71B -1.57B -2.97B -201B -3.02B -20.2B -7.91B -100B -7.93B -7.75B -331B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/08/26 | HK$16.79 | +1.70% | 16,040,473 |
| 03/08/26 | HK$16.51 | -1.26% | 15,410,088 |
| 31/07/26 | HK$16.72 | -3.69% | 28,496,954 |
| 30/07/26 | HK$17.36 | -0.69% | 26,428,043 |
| 29/07/26 | HK$17.48 | +1.98% | 13,818,660 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 1530 Stock
Select your edition
All financial news and data tailored to specific country editions
